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Objective: Urethral catheterization is often a major source of discomfort and pain to a patient after a
surgical procedure. To better understand the safety and feasibility of the early removal of urethral Foley
catheter after robotic-assisted laparoscopic radical prostatectomy by using percutaneous cystostomy
drainage, we collected the related data and present our experience.
Patients and methods: This study involved 20 patients. In the study group (10 patients), we used the
percutaneous cystostomy device (PCD) and an 18 French urethral catheter together. The urethral catheter
was removed at postoperative day (POD) 3 and the PCD was removed at POD 7. In the control group (10
patients), they had standard urethral catheterization with an 18 French catheter and the catheter was
removed at POD 7. Demographic and outcome data were measured and analyzed. Urethral pain was
recorded using the visual analog scale.
Results: The two groups were comparable in terms of age, serum prostate speciﬁc antigen level, body
mass index, clinical tumor stage, surgical duration, estimated blood loss, and surgical times. The study
group had signiﬁcantly less penile pain in POD 3 and POD 7 (mean visual analog scale: 0.9 vs. 2.2,
p < 0.001 at POD 3; 0.1 vs. 1.4, p ¼ 0.002 at POD 7). All patients had good urinary continence within 30
days and no urethra stricture was found during the follow up period.
Conclusion: The use of a percutaneous cystostomy device is feasible and safe for the early removal of
urethral Foley catheter in robotic-assisted laparoscopic radical prostatectomy to decrease penile pain and
patient discomfort.
Copyright © 2016, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Robotic-assisted laparoscopic radical prostatectomy (RALP) has
become a commonprocedure in the treatment of clinically localized
prostate cancer. This minimally invasive procedure offers the ben-
eﬁts of earlier continence, a shorter recovery time, and minimal
blood loss.1,2 Traditionally, the urethral catheter is placed for
splinting the anastomosis; it prevents the formation of cross-
synechia and drains the urinary bladder. However, the urethral
catheter is also a major source of patient discomfort in the post-
operative period.3 The duration of urethral catheterization is about
5e7 days in most minimally invasive series.4,5 The purpose of this
study was to examine the feasibility and safety of draining thertment of Surgery, Taichung
ng Road, 40705, Taiwan, ROC.
ociation. Published by Elsevier Tabladder with a percutaneous cystostomy device (PCD) for early
removal of the urethral catheter. In this study, we describe our
surgical procedures and the placement of PCD.We also discuss pain,
discomfort of patients, functional results, and related complications.
2. Patients and methods
This was a prospective, nonrandomized pilot study approved by
the Institutional Review Board of Taichung Veterans General Hos-
pital, Taichung, Taiwan (No. CE13240). All patients were completely
informed and provided consent. Between July 2012 and August
2013, 10 men undergoing RALP were offered the option of PCD
placement for urinary bladder drainage and another 10 men
undergoing RALP were involved as the control group. We used the
10 French Cystoﬁx (B. Braun Melsungen, Germany; Fig. 1), which is
a balloonless, pigtail-like tube, as the percutaneous cystostomy
device.iwan LLC. This is an open access article under the CC BY-NC-ND license (http://
Fig. 1. Percutaneous cystostomy devsice (Cystoﬁx). (A) Puncture set. (B) Balloonless
pigtail-like catheter.
Table 1
Clinical characteristics of all 20 cases.
PCD group Control group p
Mean age (range) 64.6(49e74) 68.5(61e74) 0.304
Mean body high, cm(range) 166.3(155.5e172) 164.3 (145e172) 0.404
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performed the RALP procedure as described in the previously
study.6 The vesicourethral anastomosis (VUA) was made with two
layers of reconstruction. The ﬁrst layer was posterior reconstruc-
tion with a rhabdosphincter.7 Then, anastomosis was performed by
using two 18 cm 3-O Monocryl continuous sutures (Ethicon,
Mexico), starting at the 5-o'clock position and continuing to the 11-
o'clock position where sutures were tied together.8 The VUA was
challenged with 200 mL saline intraoperatively to conﬁrm if any
leakage existed.9 The cystogramwas almost not needed prior to the
removal of the urethral catheter. In the PCD group, the PCD was
inserted in the suprapubic area under direct vision by laparoscope
in the ﬁrst three patients (Fig. 2). The PCD was put through the
wound for the second arm of the robotic system in the remaining
seven patients (Fig. 2). The 18 French urethral catheter was inserted
with a 20-mL balloon. The urethral catheter was removed at
postoperative Day (POD) 3. The PCD was removed at POD 7. In the
control group, the 18 French urethral catheter was used and was
removed at POD 7.
Thewound pain and penile painwere evaluated by visual analog
scale (VAS) at POD 3 and POD 7. We also measured urinary conti-
nence and the incidence at 6 months of bladder neck contracture
between the two groups.Fig. 2. Percutaneous cystostomy from the wound for the second arm of the robotic
system. The red arrow indicates the site of the percutaneous cystostomy. A ¼ assistant
port 1; A2 ¼ assistant port 2; C ¼ camera port; 1st ¼ ﬁrst arm of robotic system;
2nd ¼ second arm of robotic system; 3rd ¼ third arm of robotic system.The Chi-square test and Student t test were used to compare the
group characteristics and the pain score a, with critical values and
statistical signiﬁcance at p < 0.05.
3. Results
The clinical characteristics of all 20 men undergoing RALP from
July 2012 to August 2013 are outlined in Table 1. There were no dif-
ferences between the two groupswith regard to age, body high, body
weight, bodymass index (BMI), prostate-speciﬁc antigen (PSA) level,
clinical stage, American Society of Anesthesiologists (ASA) score,
surgical time, andblood loss. Themean time for PCD insertionwas6.6
minutes (range: 4e10 minutes). The VAS for wound pain and penile
pain are shown inTable 2. Themean VAS ofwound pain at POD 3 and
POD 7 in the PCD group were 2.2 (range: 1e3) and 0.5 (range: 0e1),
respectively. This was slightly lower than in the control group but
there was no statistically signiﬁcant difference between these two
groups (p¼ 0.394 and p¼ 0.081 respectively). The patients in thePCD
group had signiﬁcantly decreased penile pain in POD 3 and POD 7
(meanVAS: 0.9 vs. 2.2, p< 0.001 at POD3; 0.1 vs.1.4, p¼ 0.002 at POD
7). The PCD was dislodged at POD 4 in one patient. The urinary
bladder scan after voiding showed residual urine <50 mL. This pa-
tient was closely followed. There was no urinary leakage in either
group. All 20 patients had good urinary continence (no need for pad)
within 30 days at follow-up. At 6 months' follow-up, no patient in
either group required either cystoscopy or urethral dilation for
bladder neck contracture or urethral stricture.
4. Discussion
The urethral catheter is used for stenting the anastomosis and
drains the urinary bladder in patients undergoing RALP. However, it
is also a major source of patient discomfort in the postoperative
period. Lepor et al10 reported that 54% of patients indicated that theMean body weight, kg(range) 69.6(55.5e79) 64.4(55e78) 0.185
Mean BMI, kg/m2 (range) 25.16(22.14e29.35) 23.83(19.26e27.97) 0.302
Mean PSA, ng/ml (range) 18.42(7.15e51.8) 16.69(5.1e60) 0.517
Clinical stage 0.869
cT1 2 3
cT2 7 6
cT3 1 1
ASA 0.819
I 1 1
II 7 8
III 2 1
Mean OP time, min (range) 105(80e160) 102(70e120) 0.735
Mean blood loss, mL (range) 63(30e100) 50.5(10e100) 0.345
BMI ¼ body mass index; OP ¼ operation; PCD ¼ percutaneous cystostomy device;
PSA ¼ prostate-speciﬁc antigen.
Table 2
Evaluation of discomfort.
PCD group Control group p
VAS, mean ± SD
Wound pain, POD 3 2.2 ± 0.63 2.5 ± 0.70 0.394
Wound pain, POD 7 0.5 ± 0.53 1.1 ± 0.57 0.081
Penile pain, POD 3 0.9 ± 0.56 2.2 ± 0.42 <0.001
Penile pain, POD 7 0.1 ± 0.32 1.4 ± 0.84 0.002
PCD ¼ percutaneous cystostomy device; POD ¼ postoperative day; SD ¼ standard
deviation; VAS ¼ visual analog scale.
C.-J. Yang et al. / Urological Science 26 (2015) 240e242242urinary catheter limited their physical activities during recovery. A
meta-analysis of patients undergoing laparotomy also showed that
patients with urethral catheterization are more likely to experience
substantial bacteriuria and pain or discomfort than patients un-
dergoing suprapubic cystostomy.11
Tewari et al12 reported patients undergoing RALP with a special-
designed double balloon suprapubic catheter that passes through
the anastomosis into the urethra. There was substantially less
penile shaft or tip pain and discomfort in the study group. Orikasa
et al13 used an 18-French special handmade suprapubic cystostomy
tube in patients undergoing radical prostatectomy and also showed
fewer urinary symptoms during catheterization and painful
micturition after catheter removal. Ghani et al14 described using
primary suprapubic bladder drainage without a urethral extension
after RALP in their institution. Two hundred and two patients un-
dergoing RALP received percutaneous suprapubic tube (PST). The
patients with PST had a signiﬁcantly decreased catheter-related
discomfort and less anticholinergic medication use. However, 10
patients needed reinsertion of their urethral catheter due to PST
dislodgement (n ¼ 5) or urinary retention (n ¼ 5).15 The results of
the study also indicated that urethral stenting may not be as crucial
as previously thought in watertight VUA.
Prasad et al16 criticized the real beneﬁts of suprapubic tube after
radical prostatectomy. They point out that 79% of patients
responded that the catheter was themost bothersome immediately
after the operation but was eased considerably by the next morn-
ing. With a percutaneous suprapubic tube, patients may be at risk
of reinsertion of the urethral catheter and cicatrix formation at the
VUA. In the institution of Prasad et al,16 they performed a ran-
domized controlled trial including 58 patients to evaluate the
beneﬁts of PST in RALP.17 The results showed no difference between
the groups at any time points in pain and similar percentages of
patients cited the catheter as their greatest bother.
In our study, we used the balloonless pigtail-like tube as our
percutaneous cystostomy device. It not only helped to avoid pain
from urethral catheterization but also decreased balloon-related
discomfort. We avoided the term “suprapubic” because we put the
PCD through the wound for the second arm of the robotic system in
seven patients. Therefore, we were able to avoid another wound on
the patient's abdomen. In our study, the setting did not increase the
risk of urinary leakage from the cystostomy prior to or after removal
of the PCD. In the study, the PCD group had substantially less penile
pain in POD 3 and POD 7 (mean VAS: 0.9 vs. 2.2, p < 0.001 at POD 3;
0.1 vs.1.4, p¼ 0.002 at POD 7). As Prasad et al16 point out, the penile
painwas considerable in all 20 patients (range: 0e3) butwe thought
that any improvement in patient discomfort was a worse outcome.
All 20 patients' continencewas goodwithin 30 days and no urethral
stricture or bladder contracture was noted at 6 months' follow-up.
These ﬁndings showed that PCD did not increase the risk of incon-
tinence or cicatrix formation at the VUA.
This was a nonrandomized study with small case numbers. In
this study, using PCD for draining the bladder and early removal of
urethral catheter after RALP is feasible and safe. It may offer pa-
tients another way in which to reduce discomfort from urethral
catheterization. However, further studies are needed in order to
provide stronger evidence of the beneﬁts of this method.
5. Conclusion
A PCD can be used without increased perioperative morbidity
and will reduce penile pain. Continence rates were the same asthose with conventional urethral drainage. No urethral stricture or
bladder neck stricture was noted at 6 months' follow-up. Based on
these results, this method may be a good choice for patients un-
dergoing RALP.Conﬂicts of interest
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